Annual Drug Patent Expiration for LEVULAN
Levulan is a drug marketed by Dusa and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
Drug patent litigation for LEVULAN.
This drug has eight patent family members in three countries.
The generic ingredient in LEVULAN is aminolevulinic acid hydrochloride. One registered supplier for this compound. Additional details are available on the aminolevulinic acid hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug DUSA LEVULAN